Your browser doesn't support javascript.
Treatment recommendations for patients with vitiligo during COVID-19.
Rodrigues, Michelle; Pandya, Amit G; Hamzavi, Iltefat; Ezzedine, Khaled; Bekkenk, Marcel W; Harris, John E.
  • Rodrigues M; Chroma Dermatology, Pigment and Skin of Colour Centre, Wheelers Hill, Victoria, Australia.
  • Pandya AG; Department of Dermatology, The Royal Children's Hospital, Parkville, Victoria, Australia.
  • Hamzavi I; Department of Paediatrics, Melbourne University, Melbourne, Victoria, Australia.
  • Ezzedine K; Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, CA, USA.
  • Bekkenk MW; University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Harris JE; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA.
Australas J Dermatol ; 62(3): e481-e482, 2021 08.
Article in English | MEDLINE | ID: covidwho-1240994
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / Hypopigmentation / COVID-19 Limits: Humans Language: English Journal: Australas J Dermatol Year: 2021 Document Type: Article Affiliation country: Ajd.13610

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / Hypopigmentation / COVID-19 Limits: Humans Language: English Journal: Australas J Dermatol Year: 2021 Document Type: Article Affiliation country: Ajd.13610